These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15633864

  • 1. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking.
    Christensen RC.
    Can J Psychiatry; 2004 Nov; 49(11):788-9. PubMed ID: 15633864
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine augmentation of fluoxetine in body dysmorphic disorder.
    Phillips KA.
    Am J Psychiatry; 2005 May; 162(5):1022-3. PubMed ID: 15863817
    [No Abstract] [Full Text] [Related]

  • 3. The treatment of kleptomania with serotonin reuptake inhibitors.
    Lepkifker E, Dannon PN, Ziv R, Iancu I, Horesh N, Kotler M.
    Clin Neuropharmacol; 1999 May; 22(1):40-3. PubMed ID: 10047933
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine and olanzapine-fluoxetine combination treatment and bipolar I depression.
    Williams AB, Adetunji BA.
    Arch Gen Psychiatry; 2005 Sep; 62(9):1052; author reply 1052. PubMed ID: 16143737
    [No Abstract] [Full Text] [Related]

  • 5. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN, Wasylink S, Epperson CN, McDougle CJ.
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract] [Full Text] [Related]

  • 6. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
    Med Lett Drugs Ther; 2004 Mar 15; 46(1178):23-4. PubMed ID: 15037858
    [No Abstract] [Full Text] [Related]

  • 7. Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
    Corey-Lisle PK, Birnbaum H, Greenberg P, Marynchenko M, Dube S.
    Psychopharmacol Bull; 2003 Mar 15; 37(3):90-8. PubMed ID: 14608242
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of anorexia with a combination of high-dose olanzapine, fluoxetine and mirtazapine.
    Fountoulakis KN, Iacovides A, Siamouli M, Koumaris V, Kaprinis GS.
    Int J Clin Pharmacol Ther; 2006 Sep 15; 44(9):452-3. PubMed ID: 16995335
    [No Abstract] [Full Text] [Related]

  • 9. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
    Shelton RC, Williamson DJ, Corya SA, Sanger TM, Van Campen LE, Case M, Briggs SD, Tollefson GD.
    J Clin Psychiatry; 2005 Oct 15; 66(10):1289-97. PubMed ID: 16259543
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
    Pollack MH, Simon NM, Zalta AK, Worthington JJ, Hoge EA, Mick E, Kinrys G, Oppenheimer J.
    Biol Psychiatry; 2006 Feb 01; 59(3):211-5. PubMed ID: 16139813
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.
    J Clin Psychiatry; 2010 Apr 01; 71(4):451-62. PubMed ID: 20361905
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
    Croxtall JD, Scott LJ.
    CNS Drugs; 2010 Mar 01; 24(3):245-62. PubMed ID: 20155998
    [Abstract] [Full Text] [Related]

  • 13. Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report.
    Aldurra G, Crayton JW.
    J Clin Psychopharmacol; 2001 Jun 01; 21(3):343-4. PubMed ID: 11386500
    [No Abstract] [Full Text] [Related]

  • 14. Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.
    Duvvuri V, Cromley T, Klabunde M, Boutelle K, Kaye WH.
    Int J Eat Disord; 2012 Mar 01; 45(2):294-7. PubMed ID: 21344468
    [Abstract] [Full Text] [Related]

  • 15. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE, Corya SA, Altshuler LL, Ketter TA, McElroy SL, Case M, Briggs SD, Tohen M.
    J Clin Psychiatry; 2005 May 01; 66(5):611-6. PubMed ID: 15889948
    [Abstract] [Full Text] [Related]

  • 16. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC, Frankenburg FR, Parachini EA.
    J Clin Psychiatry; 2004 Jul 01; 65(7):903-7. PubMed ID: 15291677
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G.
    Depress Anxiety; 2006 Jul 01; 23(6):364-72. PubMed ID: 16710853
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.
    J Clin Psychiatry; 2007 Feb 01; 68(2):224-36. PubMed ID: 17335320
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
    Owen RT.
    Drugs Today (Barc); 2006 Mar 01; 42(3):185-92. PubMed ID: 16628260
    [Abstract] [Full Text] [Related]

  • 20. A novel augmentation strategy for treating resistant major depression.
    Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY.
    Am J Psychiatry; 2001 Jan 01; 158(1):131-4. PubMed ID: 11136647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.